Voices
Arutha Kulasinghe: AACR 2026 Hits Different with Lung Cancer Advocate Michel Itel by Our Side
Arutha Kulasinghe and Michel Itel - OAM

Arutha Kulasinghe: AACR 2026 Hits Different with Lung Cancer Advocate Michel Itel by Our Side

Arutha Kulasinghe, Chair in Spatial Medicine at The University of Queensland, shared a post on LinkedIn:

“American Association for Cancer Research 2026 in San Diego hits different this year.

Having lung cancer advocate Michel Itel – OAM by our side is a powerful reminder of why our research matters and who it is ultimately for. Honoured to share this space with him.

Find us at the following sessions:

19th April

Plasma proteomic profiling of lung cancer blood samples reveals immune-related inflammatory signatures as prognostic biomarkers.

Cellular decomposition and metabolic profiling of the tumor microenvironment tumor-stroma interface using high-dimensional spatial proteomics and image analytics.

20th April

Spotlight: Powering Clinical Decisions with Tissue Intelligence

Spotlight: High Sensitivity Blood Proteomics for Lung Cancer

How digital spatial profiling is changing the fight against lung cancer (Michel’s presentation!!!)

22 April

Intratumoral effector T-cells and macrophages underlie prolonged survival after PD-1 axis blockade in metastatic non-small cell lung cancer (mNSCLC).”

Arutha Kulasinghe: AACR 2026 Hits Different with Lung Cancer Advocate Michel Itel by Our Side

More posts featuring Arutha Kulasinghe.

 

AACR 2026 American Association for Cancer Research 2026 Arutha Kulasinghe cancer Lung cancer Michel Itel - OAM OncoDaily Oncology